Welcome to our dedicated page for Leidos Holdings news (Ticker: LDOS), a resource for investors and traders seeking the latest updates and insights on Leidos Holdings stock.
Leidos Holdings, Inc. provides technology, engineering and mission-focused solutions for defense, intelligence, civil, health, commercial and international customers. News about LDOS commonly covers operating results, guidance, dividends, government contract awards, defense systems, digital modernization, health services, air traffic management, autonomous systems and work for U.S. federal agencies.
Company updates also include developments across the National Security & Digital, Health & Civil, Commercial & International and Defense Systems segments, as well as completed acquisitions, material partnerships and production programs such as air and missile defense launchers and secure mission systems.
Leidos (NYSE: LDOS) has scheduled a conference call for August 4, 2020, at 8 a.m. (ET) to discuss its second-quarter financial results for the period ending July 3, 2020. The earnings press release will precede the call on the same day. Investors can listen via the internet or telephone, and a replay will be available from 11:30 a.m. (ET) on August 4 through 11:59 p.m. (ET) on August 11, 2020. Leidos reported $11.09 billion in annual revenues for fiscal year ending January 3, 2020.
Leidos (NYSE:LDOS) has secured a prime contract with Edinburgh Airport Limited to enhance its security tray systems by implementing antimicrobial technology. This technology reduces bacteria like E. coli and MRSA by 99.99%, addressing health concerns amid the ongoing pandemic. Leidos has collaborated with Edinburgh Airport since 2012 and aims to support improved health safety for travelers. The company reported revenues of approximately $11.09 billion for the fiscal year ending January 3, 2020, and has a strong portfolio of security detection solutions deployed in over 120 countries.
Leidos (NYSE:LDOS) has secured a $79 million contract from the Department of Veterans Affairs to design and implement a regional consolidated mail outpatient pharmacy system (CMOP). The contract includes a two-year performance period with 20 additional three-month options. Leidos aims to replace the existing facility in Leavenworth, Kansas, establishing a highly automated pharmacy capable of processing over 80,000 prescriptions daily. This initiative supports the VA's modernization efforts and enhances service to U.S. military veterans.
Leidos (NYSE: LDOS) and the Baltimore Ravens are distributing nearly 70,000 drug disposal packets across Baltimore as part of the "Tackling Opioid Addiction" campaign. This initiative aims to combat the opioid epidemic, which has escalated during the COVID-19 pandemic, with over 90% of drug-related deaths in Baltimore being opioid-related. The packets will allow residents to safely dispose of leftover prescriptions at home. Leidos has maintained a commitment to addressing opioid addiction since 2017, implementing several community-driven initiatives.